Raymond James Financial Inc Prothena Corp Public LTD CO Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Raymond James Financial Inc holds 22,032 shares of PRTA stock, worth $225,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,032
Previous 13,496
63.25%
Holding current value
$225,828
Previous $81,000
165.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRTA
# of Institutions
215Shares Held
34.9MCall Options Held
656KPut Options Held
1.12M-
Black Rock Inc. New York, NY3.86MShares$39.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$21.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.82MShares$18.7 Million0.27% of portfolio
-
Rubric Capital Management LP New York, NY1.54MShares$15.8 Million0.25% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.47MShares$15.1 Million1.35% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $481M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...